About: Quadrivalent HPV vaccine administered to women who became pregnant during trials did not appear to adversely affect pregnancy outcome; however, use during pregnancy is not recommended

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Quadrivalent HPV vaccine administered to women who became pregnant during trials did not appear to adversely affect pregnancy outcome; however, use during pregnancy is not recommended Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebm/2010/volume_15/issue_3/w
Subject	Therapeutics
Title	Quadrivalent HPV vaccine administered to women who became pregnant during trials did not appear to adversely affect pregnancy outcome; however, use during pregnancy is not recommended
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebm/2010/volume_15/issue_3/B3555EDB417538C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebm/2010/volume_15/issue_3/B3555EDB417538C5E053120B220A16A6/m/web
related by	http://hub.abes.fr/bmj/periodical/ebm/2010/volume_15/issue_3/B3555EDB417538C5E053120B220A16A6/authorship/1
Abstract	Commentary on: GarlandSMAultKAGallSA. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet Gynecol2009;114:1179-88.
article type	article-commentary
publisher identifier	ebmed1066
is part of this journal	Evidence Based Medicine

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata